-
ABOUT USHebei Guangxiang Pharmaceutical Co., Ltd. is specializing in the production of bulk pharmaceuticals, fine pharmaceuticals, intermediate compounds and biopharmaceutical preparations.
-
News CenterAt the forefront of corporate development, we champion the positive energy of the Four Pharmaceutical Companies: fulfilling our duties conscientiously, stepping up to the plate and taking proactive action, embracing new missions, and conducting effective new publicity. In doing so, we aim to enhance the overall competence of our employees, stimulate their enthusiasm, initiative, and creativity, and provide robust ideological guidance and powerful spiritual strength to drive the enterprise forward.
-
INNOVATIONDevelops fine, series, high-end bulk pharmaceutical intermediates and innovative bulk pharmaceutical intermediates with high added value to build variety competition advantages.
-
-
RECRUITGuangxiang has jointly established engineering laboratories, technology research centers and other high-level innovation platforms with CAS, Zhejiang University, Tianjin University and other universities.
-
CONTACTWith stable production, high-quality and reliable service, the company's products have been sold to more than 80 countries such as the United States, the United Kingdom, Germany and the Netherlands
Media Spotlight · Cangzhou Daily | Hebei Guangxiang Pharmaceutical: Secures the “Green Pass” for International Trade
Category:
TIME：2025-12-20
According to available information, AEO—“Authorized Economic Operator”—represents the highest credit rating conferred by customs authorities on enterprises, and the AEO Advanced Certification is widely regarded as a “green pass” for global international trade. As one of China’s leading enterprises in the R&D, production, and export of chemical APIs, Guangxiang Pharmaceutical has, in recent years, closely aligned its efforts with evolving domestic and international market demands, relentlessly pursuing advancements in quality enhancement and green manufacturing. By leveraging cutting-edge technologies such as continuous-flow microreactors and continuous crystallization, the company has successfully addressed numerous common and critical technical challenges in the production of flagship products like caffeine and metronidazole, optimized its manufacturing processes, implemented end-to-end green management across the entire value chain, and significantly improved product yields and quality metrics. Its product quality now rivals the industry’s leading standards and enjoys broad recognition in international markets.
Zhu Shujie, Chairman of Guangxiang Pharmaceutical, stated that the company’s next step will be to further identify additional market entry points for its export-oriented products in overseas markets, leverage the prestigious AEO Advanced Certification as a “golden brand,” and shift its foreign trade operations from “volume-based exports” to “value-driven exports.” The company is committed to making new contributions to the development of Hebei’s pharmaceutical industry and to building Cangzhou into a modern, coastal economic powerhouse.
(Source: Cangzhou Daily, December 20, 2025)
Keywords:
Recommended News
Share to
SERVICE HOTLINE
E-mail: hbgxzy@hebgxzy.com
Address: The west of Jingliu Road, lingang economic nad technological development zone, cangzhou city, Hebei province
Website
Official WeChat
e-Home
